journal article·2026-04Open access

Astrocyte Enrichment of 3D Cortical Constructs Enhances Brain Repair

Elisa M. Cruz, Luana C. Soares, Gretchen Greene, Fernando Messore, Mohammed Abuelem, Mingyu Li, Caroline Andersen, Mirriam Domocos, Elisa Vitiello, Rabeah Abdul Razak, Marlene Lawston, Gabriel Moser, Talia Vasaturo‐Kolodner, Mona Barkat, Roslyn M. Bill, Edward Mann, Linna Zhou, Mootaz M. Salman, Hagan Bayley, Zoltán Molnár, Francis G. Szele

Advanced Science· Volume 13· Issue 20

Abstract

ABSTRACT Regenerative medicine offers a promising approach to treat brain injuries, yet challenges persist in promoting neuronal survival and integration. Recent studies demonstrate that human cells implanted into rodent brains can exhibit plasticity, integrate into neural circuits and alleviate functional deficits. However, integration is often poor, with inadequate vascularization, and insufficient support cells such as astrocytes. Astrocytes play a crucial role in neuronal development and recovery by releasing growth factors, facilitating synaptogenesis, and promoting blood vessel formation. This study investigated human neuronal progenitor cells cultured alone or cultured with mouse astrocytes and formed into 3D constructs using microfluidics. Co‐cultures exhibited enhanced neuronal maturation, viability, and density. Following implantation into mouse brains, co‐cultures reduced lesion size, increased axonal growth, and improved astrocyte coupling to blood vessels within the graft. Additionally, we show that NPCs and co‐cultures increased astrocyte size in implants. Deconvolved high‐resolution microscopy identified synapses and optogenetics showed functional connections between the host and implants. These findings underscore the essential role of astrocytes in enhancing neuronal tissue integration and advancing brain injury treatments.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Neurogenesis and neuroplasticity mechanisms · Barrier Structure and Function Studies · Neuroinflammation and Neurodegeneration Mechanisms

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Physiology, Anatomy and Genetics University of Oxford Oxford UK

Aston Institute for Membrane Excellence and School of Biosciences Aston University Birmingham UK

BHF Oxford Centre of Research Excellence University of Oxford Oxford UK

Kavli Institute for NanoScience Discovery University of Oxford Oxford UK

British Heart Foundation (BHF) ‐ UK Dementia Research Institute (UK DRI) Centre for Vascular Dementia Research at the University of Oxford Oxford UK

National Institute of Neurological Disorders NIH Bethesda MD USA

Faculty of Medicine Alexandria University Alexandria Egypt

National Institute of Mental Health NIH Bethesda MD USA

Department of Chemistry University of Oxford Oxford UK

Department of Biochemistry University of Oxford Oxford UK

References (82)

Show source-provided references
1. 10.1016/j.conb.2014.03.00510.1016/j.conb.2014.03.005 ↗
2. 10.1038/nrn348410.1038/nrn3484 ↗
3. 10.1177/0883073803018009090110.1177/08830738030180090901 ↗
4. 10.1016/j.neuron.2015.02.00110.1016/j.neuron.2015.02.001 ↗
5. 10.1038/nn197010.1038/nn1970 ↗
6. 10.1093/cercor/10.5.44310.1093/cercor/10.5.443 ↗
7. 10.1016/0165-3806(94)90203-810.1016/0165-3806(94)90203-8 ↗
8. 10.1016/j.celrep.2018.04.09410.1016/j.celrep.2018.04.094 ↗
9. 10.1016/j.neuron.2012.12.01110.1016/j.neuron.2012.12.011 ↗
10. 10.1038/nature0728710.1038/nature07287 ↗
11. 10.1038/s41587-024-02157-810.1038/s41587-024-02157-8 ↗
12. 10.1371/journal.pone.004662810.1371/journal.pone.0046628 ↗
13. 10.1177/108705711769679510.1177/1087057117696795 ↗
14. 10.3389/fmolb.2020.0003310.3389/fmolb.2020.00033 ↗
15. 10.1002/adfm.20190914610.1002/adfm.201909146 ↗
16. 10.1002/adma.20200218310.1002/adma.202002183 ↗
17. 10.1038/s41596-018-0032-710.1038/s41596-018-0032-7 ↗
18. 10.1038/s41598-017-06358-x10.1038/s41598-017-06358-x ↗
19. 10.1038/s41467-023-41356-w10.1038/s41467-023-41356-w ↗
20. 10.4155/bio.12.13310.4155/bio.12.133 ↗
21. 10.1038/micronano.2015.4510.1038/micronano.2015.45 ↗
22. 10.1186/s12575-023-00194-210.1186/s12575-023-00194-2 ↗
23. 10.1038/s41598-019-53414-910.1038/s41598-019-53414-9 ↗
24. 10.1038/s41593-018-0175-410.1038/s41593-018-0175-4 ↗
25. 10.3389/fncel.2015.0007010.3389/fncel.2015.00070 ↗
26. 10.1038/s41586-025-09010-110.1038/s41586-025-09010-1 ↗
27. 10.1016/j.nbd.2013.11.00310.1016/j.nbd.2013.11.003 ↗
28. 10.3389/fendo.2019.0082210.3389/fendo.2019.00822 ↗
29. 10.1038/s41467-024-50190-710.1038/s41467-024-50190-7 ↗
30. 10.1002/advs.20190115210.1002/advs.201901152 ↗
31. 10.1038/s41392-025-02249-010.1038/s41392-025-02249-0 ↗
32. 10.1155/2014/32120910.1155/2014/321209 ↗
33. 10.1016/j.nbd.2019.10467210.1016/j.nbd.2019.104672 ↗
34. 10.3390/biomedicines1208169310.3390/biomedicines12081693 ↗
35. 10.1523/JNEUROSCI.2424-23.202410.1523/JNEUROSCI.2424-23.2024 ↗
36. 10.1038/nprot.2012.11610.1038/nprot.2012.116 ↗
37. 10.2174/138945011766616010112070310.2174/1389450117666160101120703 ↗
38. 10.1523/JNEUROSCI.4707-08.200910.1523/JNEUROSCI.4707-08.2009 ↗
39. 10.3389/fnana.2023.113072910.3389/fnana.2023.1130729 ↗
40. 10.1007/s00429-017-1383-510.1007/s00429-017-1383-5 ↗
41. 10.1186/s13024-021-00487-810.1186/s13024-021-00487-8 ↗
42. 10.1016/j.neulet.2013.12.03010.1016/j.neulet.2013.12.030 ↗
43. 10.1016/j.neuron.2019.08.00910.1016/j.neuron.2019.08.009 ↗
44. 10.1038/nn.304110.1038/nn.3041 ↗
45. 10.1016/S0304-3940(02)00611-010.1016/S0304-3940(02)00611-0 ↗
46. 10.1523/JNEUROSCI.15-06-04429.199510.1523/JNEUROSCI.15-06-04429.1995 ↗
47. 10.3389/fnins.2024.142552510.3389/fnins.2024.1425525 ↗
48. 10.1002/glia.2044510.1002/glia.20445 ↗
49. 10.3389/fncel.2023.109450310.3389/fncel.2023.1094503 ↗
50. 10.3389/fneur.2022.83559710.3389/fneur.2022.835597 ↗
51. 10.1016/j.neuron.2007.04.01910.1016/j.neuron.2007.04.019 ↗
52. 10.3390/brainsci1012090910.3390/brainsci10120909 ↗
53. 10.1016/j.celrep.2021.10904810.1016/j.celrep.2021.109048 ↗
54. Mansour A. A. · Nature Biotechnology · 2018
55. 10.1152/physrev.00011.201310.1152/physrev.00011.2013 ↗
56. 10.1186/1742-2094-9-27910.1186/1742-2094-9-279 ↗
57. 10.1002/glia.2003910.1002/glia.20039 ↗
58. 10.1074/jbc.M109.01009010.1074/jbc.M109.010090 ↗
59. 10.1007/s00441-008-0658-910.1007/s00441-008-0658-9 ↗
60. 10.3389/fnins.2022.96677210.3389/fnins.2022.966772 ↗
61. 10.1038/s41380-020-00910-410.1038/s41380-020-00910-4 ↗
62. 10.1038/s41586-022-05277-w10.1038/s41586-022-05277-w ↗
63. 10.1016/j.neuron.2017.07.03510.1016/j.neuron.2017.07.035 ↗
64. 10.1523/ENEURO.0148-24.202410.1523/ENEURO.0148-24.2024 ↗
65. 10.1016/j.celrep.2018.04.06610.1016/j.celrep.2018.04.066 ↗
66. 10.1016/j.stemcr.2021.07.00110.1016/j.stemcr.2021.07.001 ↗
67. 10.1016/j.stem.2012.12.01510.1016/j.stem.2012.12.015 ↗
68. 10.1016/j.tins.2006.08.00410.1016/j.tins.2006.08.004 ↗
69. 10.7554/eLife.4007010.7554/eLife.40070 ↗
70. Appearance of ß‐dystroglycan precedes the formation of glio‐vascular end‐feet in developing rat brain
71. Traumatic brain injury in infants and toddlers, 0–3 years old
72. 10.1038/pr.2011.6410.1038/pr.2011.64 ↗
73. 10.1002/wsbm.155710.1002/wsbm.1557 ↗
74. 10.2176/nmc.ra.2016-019110.2176/nmc.ra.2016-0191 ↗
75. 10.1186/s12974-022-02390-510.1186/s12974-022-02390-5 ↗
76. 10.3791/5007910.3791/50079 ↗
77. 10.1038/tp.2013.7110.1038/tp.2013.71 ↗
78. 10.1038/nprot.2017.02010.1038/nprot.2017.020 ↗
79. 10.1016/j.jneumeth.2016.09.00110.1016/j.jneumeth.2016.09.001 ↗
80. 10.3389/fncel.2022.95887610.3389/fncel.2022.958876 ↗
81. 10.1039/C5LC00133A10.1039/C5LC00133A ↗
82. 10.3389/fnins.2022.82988410.3389/fnins.2022.829884 ↗